Glück Conviction Score™ ⓘ
Score-Verlauf (90 Tage)
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 67.43 | +3.1 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 69.24 | +0.4 % vs SMA200 | |
| SMA-Cross | Bärisch | 10 % | DEATH | vor 36 Tagen @ 68.40 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 69.24 | EMA50: 68.20 | |
| MACD-Histogramm | Bullisch | 10 % | 0.065 | Bullisch | |
| RSI(14) | Neutral | 10 % | 52.4 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 58.3 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 20.3 | +DI: 19.8 / −DI: 14.6 | |
| Z-Score(60) | Neutral | 5 % | 1.02 | In Range | |
| 52W-Position | Neutral | 5 % | 59.8 % | Hoch 81.23 / Tief 52.02 | |
| Bollinger(20,2σ) | Neutral | 5 % | 56.7 % | Upper 72.24 / Mid 69.08 / Lower 65.91 | |
| LinReg-Slope(60) | Bullisch | 10 % | +0.1168 | R²=0.55 / annualisiert +44.1 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -6.100 | 69,69 | -425.121,20 | -96,4% | |
| 2026-06-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.000 | 68,74 | -137.472,00 | -31,2% | |
| 2026-06-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -1.500 | 67,68 | -101.512,50 | -23,0% | |
| 2026-06-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -400 | 66,37 | -26.547,20 | -6,0% | |
| 2026-06-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -3.400 | 66,75 | -226.933,00 | -51,5% | |
| 2026-06-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -16.600 | 66,31 | -1.100.812,40 | -249,7% | |
| 2026-06-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -1.610 | 66,39 | -106.884,68 | -24,2% | |
| 2026-06-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -12.989 | 67,41 | -875.588,49 | -198,6% | |
| 2026-06-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -5.401 | 68,35 | -369.136,75 | -83,7% | |
| 2026-06-01 | Connaughton Bernadette | Director | Open Market Sale | -1.625 | 66,21 | -107.591,25 | -24,4% | |
| 2026-05-13 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.100 | 68,10 | -143.014,20 | -32,4% | |
| 2026-05-13 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -3.950 | 69,79 | -275.658,65 | -62,5% | |
| 2026-05-13 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -3.350 | 68,88 | -230.748,00 | -52,3% | |
| 2026-05-13 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -600 | 70,81 | -42.487,20 | -9,6% | |
| 2026-05-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -1.398 | 70,29 | -98.261,23 | -22,3% | |
| 2026-05-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -9.802 | 71,37 | -699.568,74 | -158,7% | |
| 2026-05-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -5.900 | 72,15 | -425.673,20 | -96,6% | |
| 2026-05-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.800 | 73,12 | -204.738,80 | -46,4% | |
| 2026-05-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -100 | 67,85 | -6.785,00 | -1,5% | |
| 2026-05-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -6.700 | 66,33 | -444.390,90 | -100,8% | |
| 2026-05-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -9.725 | 64,63 | -628.536,48 | -142,6% | |
| 2026-05-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -3.575 | 65,46 | -234.012,35 | -53,1% | |
| 2026-05-01 | Connaughton Bernadette | Director | Open Market Sale | -1.625 | 63,48 | -103.155,00 | -23,4% | |
| 2026-04-06 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -4.100 | 64,02 | -262.461,50 | -59,5% | |
| 2026-04-06 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -5.900 | 63,14 | -372.520,10 | -84,5% | |
| 2026-04-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -15.800 | 64,06 | -1.012.195,40 | -229,6% | |
| 2026-04-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -4.200 | 64,89 | -272.525,40 | -61,8% | |
| 2026-04-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -1.000 | 65,71 | -65.714,00 | -14,9% | |
| 2026-04-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -19.000 | 65,36 | -1.241.802,00 | -281,7% | |
| 2026-03-10 | Caudill Cortney | Officer, SVP, CHIEF OPERATING OFFICER | Open Market Sale | -8.857 | 67,64 | -599.087,48 | -135,9% | |
| 2026-03-09 | Caudill Cortney | Officer, SVP, CHIEF OPERATING OFFICER | Open Market Sale | -17.900 | 67,75 | -1.212.742,90 | -275,1% | |
| 2026-03-09 | Caudill Cortney | Officer, SVP, CHIEF OPERATING OFFICER | Open Market Sale | -2.100 | 68,25 | -143.329,20 | -32,5% | |
| 2026-03-04 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -7.329 | 69,94 | -512.619,58 | -116,3% | |
| 2026-03-04 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.671 | 70,95 | -189.494,10 | -43,0% | |
| 2026-03-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -13.481 | 68,85 | -928.166,85 | -210,5% | |
| 2026-03-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -6.519 | 69,33 | -451.981,83 | -102,5% | |
| 2026-03-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -4.100 | 69,20 | -283.707,70 | -64,4% | |
| 2026-03-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -15.322 | 69,80 | -1.069.460,28 | -242,6% | |
| 2026-03-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -578 | 70,46 | -40.726,46 | -9,2% | |
| 2026-02-05 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -5.376 | 78,38 | -421.365,50 | -95,6% | |
| 2026-02-05 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -4.624 | 78,94 | -365.000,06 | -82,8% | |
| 2026-02-04 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -10.100 | 77,54 | -783.154,00 | -177,6% | |
| 2026-02-04 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -9.900 | 76,94 | -761.666,40 | -172,8% | |
| 2026-02-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.551 | 74,88 | -191.016,33 | -43,3% | |
| 2026-02-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -9.659 | 75,94 | -733.543,10 | -166,4% | |
| 2026-02-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -7.790 | 76,73 | -597.757,86 | -135,6% | |
| 2026-01-05 | Connaughton Bernadette | Director | Open Market Sale | -2.000 | 70,25 | -140.500,00 | -31,9% | |
| 2025-12-01 | Connaughton Bernadette | Director | Open Market Sale | -829 | 71,60 | -59.356,40 | -13,5% | |
| 2025-12-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -261 | 71,60 | -18.687,60 | -4,2% | |
| 2025-12-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -500 | 70,36 | -35.181,00 | -8,0% | |
| 2025-12-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -5.402 | 69,44 | -375.120,28 | -85,1% | |
| 2025-12-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -10.406 | 68,51 | -712.935,87 | -161,7% | |
| 2025-11-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -6.784 | 71,09 | -482.267,78 | -109,4% | |
| 2025-11-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -498 | 71,67 | -35.690,17 | -8,1% | |
| 2025-11-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -12.718 | 70,22 | -893.032,52 | -202,6% | |
| 2025-11-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -4.000 | 68,80 | -275.180,00 | -62,4% | |
| 2025-11-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -11.500 | 69,73 | -801.906,50 | -181,9% | |
| 2025-11-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -4.500 | 67,89 | -305.514,00 | -69,3% | |
| 2025-11-10 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -100 | 69,30 | -6.930,00 | -1,6% | |
| 2025-11-10 | Connaughton Bernadette | Director | Open Market Sale | -2.000 | 68,48 | -136.960,00 | -31,1% | |
| 2025-11-10 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -19.900 | 68,71 | -1.367.408,60 | -310,2% | |
| 2025-11-01 | Caudill Cortney | Officer, SVP, CHIEF OPERATING OFFICER | Open Market Sale | -4.263 | 65,19 | -277.904,97 | -63,0% | |
| 2025-10-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.334 | 69,83 | -162.983,22 | -37,0% | |
| 2025-10-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -14.235 | 68,47 | -974.698,92 | -221,1% | |
| 2025-10-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.707 | 70,58 | -191.065,47 | -43,3% | |
| 2025-10-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -724 | 71,67 | -51.890,53 | -11,8% | |
| 2025-10-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -700 | 73,24 | -51.265,20 | -11,6% | |
| 2025-10-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -10.200 | 71,28 | -727.035,60 | -164,9% | |
| 2025-10-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -6.600 | 70,51 | -465.359,40 | -105,6% | |
| 2025-10-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.400 | 72,07 | -172.956,00 | -39,2% | |
| 2025-10-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -100 | 74,67 | -7.466,50 | -1,7% | |
| 2025-10-01 | Connaughton Bernadette | Director | Open Market Sale | -1.500 | 75,09 | -112.629,00 | -25,5% | |
| 2025-10-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -11.705 | 75,11 | -879.150,85 | -199,4% | |
| 2025-10-01 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -8.295 | 75,69 | -627.873,44 | -142,4% | |
| 2025-10-01 | Connaughton Bernadette | Director | Open Market Sale | -500 | 75,70 | -37.852,00 | -8,6% | |
| 2025-09-22 | LaBrosse Nicole | Officer, SVP, CHIEF FINANCIAL OFFICER | Open Market Sale | -1.913 | 77,83 | -148.883,05 | -33,8% | |
| 2025-09-22 | LaBrosse Nicole | Officer, SVP, CHIEF FINANCIAL OFFICER | Open Market Sale | -314 | 78,67 | -24.701,44 | -5,6% | |
| 2025-09-10 | LaBrosse Nicole | Officer, SVP, CHIEF FINANCIAL OFFICER | Open Market Sale | -6.760 | 75,29 | -508.967,16 | -115,4% | |
| 2025-09-10 | LaBrosse Nicole | Officer, SVP, CHIEF FINANCIAL OFFICER | Open Market Sale | -13.240 | 75,93 | -1.005.299,96 | -228,0% | |
| 2025-09-04 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -9.900 | 73,54 | -728.006,40 | -165,1% | |
| 2025-09-04 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -7.800 | 74,33 | -579.750,60 | -131,5% | |
| 2025-09-04 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -2.300 | 75,22 | -173.015,20 | -39,2% | |
| 2025-09-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -10.500 | 74,63 | -783.636,00 | -177,8% | |
| 2025-09-03 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -9.500 | 74,22 | -705.090,00 | -159,9% | |
| 2025-09-02 | Connaughton Bernadette | Director | Open Market Sale | -100 | 71,71 | -7.171,00 | -1,6% | |
| 2025-09-02 | Connaughton Bernadette | Director | Open Market Sale | -923 | 74,11 | -68.404,45 | -15,5% | |
| 2025-09-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -16.288 | 73,70 | -1.200.393,02 | -272,3% | |
| 2025-09-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -3.412 | 74,15 | -252.989,56 | -57,4% | |
| 2025-09-02 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -300 | 72,49 | -21.745,50 | -4,9% | |
| 2025-09-02 | Connaughton Bernadette | Director | Open Market Sale | -2.977 | 73,62 | -219.160,79 | -49,7% | |
| 2025-08-13 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -14.948 | 64,15 | -958.839,46 | -217,5% | |
| 2025-08-13 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -5.052 | 64,83 | -327.511,06 | -74,3% | |
| 2025-08-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -13.042 | 63,24 | -824.802,16 | -187,1% | |
| 2025-08-12 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -6.958 | 64,00 | -445.318,96 | -101,0% | |
| 2025-08-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -18.717 | 63,01 | -1.179.320,74 | -267,5% | |
| 2025-08-11 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -1.283 | 63,60 | -81.596,23 | -18,5% | |
| 2025-07-10 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -15.746 | 57,62 | -907.237,28 | -205,8% | |
| 2025-07-10 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -4.254 | 56,74 | -241.380,47 | -54,8% | |
| 2025-07-09 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -19.792 | 56,43 | -1.116.783,39 | -253,3% | |
| 2025-07-09 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -208 | 57,08 | -11.871,81 | -2,7% | |
| 2025-07-08 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -3.598 | 54,48 | -196.029,83 | -44,5% | |
| 2025-07-08 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -16.402 | 55,74 | -914.214,68 | -207,4% | |
| 2025-06-24 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -4.489 | 53,11 | -238.406,30 | -54,1% | |
| 2025-06-24 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -15.511 | 53,91 | -836.213,52 | -189,7% | |
| 2025-06-23 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -20.000 | 52,57 | -1.051.460,00 | -238,5% | |
| 2025-06-20 | Torley Helen | Director, Officer, PRESIDENT AND CEO | Open Market Sale | -20.000 | 52,96 | -1.059.200,00 | -240,3% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 20.890.053 | 18.903.857 | 1.986.196 | 867.076.530 | Aufgestockt | +10,5% | |
| VANGUARD GROUP INC | 11.566.896 | 0 | 11.566.896 | 778.452.101 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.271.218 | 0 | 5.271.218 | 340.678.819 | Neu | +100,0% | |
| STATE STREET CORP | 13.975.854 | 14.759.672 | -783.818 | 330.786.146 | Reduziert | -5,3% | |
| Invesco Ltd. | 10.512.494 | 8.148.063 | 2.364.431 | 267.644.237 | Aufgestockt | +29,0% | |
| BANK OF AMERICA CORP /DE/ | 5.026.109 | 6.917.832 | -1.891.723 | 190.977.806 | Reduziert | -27,3% | |
| Boston Partners | 2.683.683 | 487.069 | 2.196.614 | 173.432.991 | Aufgestockt | +451,0% | |
| MORGAN STANLEY | 4.977.309 | 12.433.299 | -7.455.990 | 168.688.554 | Reduziert | -60,0% | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2.525.975 | 1.842.956 | 683.019 | 163.253.764 | Aufgestockt | +37,1% | |
| GEODE CAPITAL MANAGEMENT, LLC | 2.505.786 | 2.433.193 | 72.593 | 161.982.673 | Aufgestockt | +3,0% | |
| SNYDER CAPITAL MANAGEMENT L P | 2.323.077 | 2.399.188 | -76.111 | 150.140.467 | Reduziert | -3,2% | |
| DIMENSIONAL FUND ADVISORS LP | 2.079.827 | 2.104.157 | -24.330 | 134.398.148 | Reduziert | -1,2% | |
| NORGES BANK | 1.904.922 | 0 | 1.904.922 | 128.201.251 | Neu | +100,0% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.918.149 | 3.222.507 | -1.304.358 | 123.969.970 | Reduziert | -40,5% | |
| D. E. Shaw & Co., Inc. | 1.899.408 | 1.649.466 | 249.942 | 122.758.740 | Aufgestockt | +15,2% | |
| ALLIANCEBERNSTEIN L.P. | 1.736.501 | 1.835.486 | -98.985 | 116.866.517 | Reduziert | -5,4% | |
| WELLS FARGO & COMPANY/MN | 9.092.737 | 12.547.517 | -3.454.780 | 108.634.839 | Reduziert | -27,5% | |
| ROYAL LONDON ASSET MANAGEMENT LTD | 1.610.553 | 1.371.271 | 239.282 | 104.090.040 | Aufgestockt | +17,4% | |
| JUPITER ASSET MANAGEMENT LTD | 1.608.256 | 1.569.559 | 38.697 | 103.941.586 | Aufgestockt | +2,5% | |
| TWO SIGMA INVESTMENTS, LP | 1.584.961 | 717.369 | 867.592 | 102.436.029 | Aufgestockt | +120,9% | |
| FIRST TRUST ADVISORS LP | 1.482.340 | 1.011.782 | 470.558 | 95.803.603 | Aufgestockt | +46,5% | |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1.465.283 | 1.379.575 | 85.708 | 94.701.251 | Aufgestockt | +6,2% | |
| MIZUHO MARKETS AMERICAS LLC | 1.323.544 | 1.268.673 | 54.871 | 85.540.649 | Aufgestockt | +4,3% | |
| FRANKLIN RESOURCES INC | 9.528.039 | 9.309.678 | 218.361 | 85.510.936 | Aufgestockt | +2,3% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.289.533 | 1.241.829 | 47.704 | 83.342.518 | Aufgestockt | +3,8% | |
| CONGRESS ASSET MANAGEMENT CO | 1.280.592 | 1.302.180 | -21.588 | 82.764.661 | Reduziert | -1,7% | |
| JANUS HENDERSON GROUP PLC | 1.233.658 | 863.956 | 369.702 | 79.741.989 | Aufgestockt | +42,8% | |
| Stephens Investment Management Group LLC | 1.218.668 | 1.223.665 | -4.997 | 78.762.513 | Reduziert | -0,4% | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 1.186.951 | 1.518.405 | -331.454 | 76.713.000 | Reduziert | -21,8% | |
| BANK OF MONTREAL /CAN/ | 7.689.597 | 6.784.267 | 905.330 | 76.612.235 | Aufgestockt | +13,3% | |
| TD ASSET MANAGEMENT INC | 1.168.666 | 931.704 | 236.962 | 75.530.884 | Aufgestockt | +25,4% | |
| Epoch Investment Partners, Inc. | 1.138.377 | 533.359 | 605.018 | 73.573.306 | Aufgestockt | +113,4% | |
| FEDERATED HERMES, INC. | 1.123.266 | 1.574.621 | -451.355 | 72.596.682 | Reduziert | -28,7% | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 1.121.200 | 1.224.009 | -102.809 | 72.463.156 | Reduziert | -8,4% | |
| NORTHERN TRUST CORP | 1.111.231 | 1.096.307 | 14.924 | 71.818.860 | Aufgestockt | +1,4% | |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 55.026.000 | 39.626.000 | 15.400.000 | 71.004.180 | Aufgestockt | +38,9% | |
| CITADEL ADVISORS LLC | 44.828.851 | 65.884.900 | -21.056.049 | 70.746.121 | Reduziert | -32,0% | |
| Point72 Asset Management, L.P. | 54.851.000 | 48.351.000 | 6.500.000 | 68.677.931 | Aufgestockt | +13,4% | |
| MILLENNIUM MANAGEMENT LLC | 29.394.284 | 21.436.948 | 7.957.336 | 67.606.022 | Aufgestockt | +37,1% | |
| AQR CAPITAL MANAGEMENT LLC | 1.016.429 | 1.158.359 | -141.930 | 64.817.665 | Reduziert | -12,3% | |
| Pacer Advisors, Inc. | 937.293 | 0 | 937.293 | 63.079.819 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 28.903.537 | 0 | 28.903.537 | 62.487.438 | Neu | +100,0% | |
| UBS Group AG | 979.333 | 1.366.973 | -387.640 | 59.140.076 | Reduziert | -28,4% | |
| Capital World Investors | 3.026.902 | 3.034.874 | -7.972 | 59.113.736 | Reduziert | -0,3% | |
| LMR Partners LLP | 45.000.000 | 40.508.000 | 4.492.000 | 57.712.500 | Aufgestockt | +11,1% | |
| JANE STREET GROUP, LLC | 1.004.407 | 226.644 | 777.763 | 57.441.107 | Aufgestockt | +343,2% | |
| Nuveen, LLC | 12.932.124 | 12.984.891 | -52.767 | 51.064.011 | Reduziert | -0,4% | |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 789.429 | 876.957 | -87.528 | 51.020.796 | Reduziert | -10,0% | |
| GOLDMAN SACHS GROUP INC | 1.630.140 | 1.358.139 | 272.001 | 48.345.683 | Aufgestockt | +20,0% | |
| Gotham Asset Management, LLC | 746.841 | 439.708 | 307.133 | 48.268.334 | Aufgestockt | +69,8% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 20.890.053 | 18.903.857 | +10,5% | 867.076.530 | 11,20 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.271.218 | 0 | +100,0% | 340.678.819 | 4,40 |
| STATE STREET CORP | 13.975.854 | 14.759.672 | -5,3% | 330.786.146 | 4,27 |
| Invesco Ltd. | 10.512.494 | 8.148.063 | +29,0% | 267.644.237 | 3,46 |
| BANK OF AMERICA CORP /DE/ | 5.026.109 | 6.917.832 | -27,3% | 190.977.806 | 2,47 |
| Boston Partners | 2.683.683 | 487.069 | +451,0% | 173.432.991 | 2,24 |
| MORGAN STANLEY | 4.977.309 | 12.433.299 | -60,0% | 168.688.554 | 2,18 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2.525.975 | 1.842.956 | +37,1% | 163.253.764 | 2,11 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.505.786 | 2.433.193 | +3,0% | 161.982.673 | 2,09 |
| SNYDER CAPITAL MANAGEMENT L P | 2.323.077 | 2.399.188 | -3,2% | 150.140.467 | 1,94 |
| DIMENSIONAL FUND ADVISORS LP | 2.079.827 | 2.104.157 | -1,2% | 134.398.148 | 1,74 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.918.149 | 3.222.507 | -40,5% | 123.969.970 | 1,60 |
| D. E. Shaw & Co., Inc. | 1.899.408 | 1.649.466 | +15,2% | 122.758.740 | 1,59 |
| ALLIANCEBERNSTEIN L.P. | 1.736.501 | 1.835.486 | -5,4% | 116.866.517 | 1,51 |
| WELLS FARGO & COMPANY/MN | 9.092.737 | 12.547.517 | -27,5% | 108.634.839 | 1,40 |
| ROYAL LONDON ASSET MANAGEMENT LTD | 1.610.553 | 1.371.271 | +17,4% | 104.090.040 | 1,34 |
| JUPITER ASSET MANAGEMENT LTD | 1.608.256 | 1.569.559 | +2,5% | 103.941.586 | 1,34 |
| TWO SIGMA INVESTMENTS, LP | 1.584.961 | 717.369 | +120,9% | 102.436.029 | 1,32 |
| FIRST TRUST ADVISORS LP | 1.482.340 | 1.011.782 | +46,5% | 95.803.603 | 1,24 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1.465.283 | 1.379.575 | +6,2% | 94.701.251 | 1,22 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 657 | 795,1 | 8.624 |
| 31.12.2025 | ✓ | 647 | 1.139,8 | 9.582 |
| 30.09.2025 | ✓ | 652 | 1.694,1 | 10.713 |
| 30.06.2025 | ✓ | 600 | 1.555,1 | 7.389 |
| 31.03.2025 | ✓ | 586 | 1.750,5 | 9.813 |
| 31.12.2024 | ✓ | 541 | 1.753,5 | 7.398 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| NORGES BANK | 1.904.922 | 128.201.251 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.842.956 | 124.030.939 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 1.518.405 | 102.189.000 |
| Lombard Odier Asset Management (Europe) Ltd | 15.493.000 | 20.575.943 |
| SILVERBACK ASSET MANAGEMENT LLC | 9.819.000 | 10.629.068 |
| GLENMEDE TRUST CO NA | 119.866 | 8.066.981 |
| LGT Fund Management Co Ltd. | 88.000 | 5.957.600 |
| Pinnacle Financial Partners, Inc. | 84.037 | 5.655.690 |
| Assenagon Asset Management S.A. | 72.085 | 4.851.321 |
| Verity Asset Management, Inc. | 53.118 | 3.574.841 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | 65.884.900 | 51.549.499 | +359.6 % | 79.513.851 |
| Point72 Asset Management, L.P. | 48.351.000 | 14.405.000 | +42.4 % | 62.361.850 |
| Focus Partners Wealth | 6.199.899 | 6.076.806 | +4936.8 % | 15.455.060 |
| ANGELO GORDON & CO., L.P. | 10.000.000 | 5.000.000 | +100.0 % | 10.775.000 |
| Jain Global LLC | 25.000.000 | 5.000.000 | +25.0 % | 33.228.250 |
| CITIGROUP INC | 5.510.103 | 3.838.212 | +229.6 % | 39.445.595 |
| Warberg Asset Management LLC | 8.000.000 | 2.858.000 | +55.6 % | 10.630.367 |
| PIER 88 INVESTMENT PARTNERS LLC | 2.530.280 | 2.439.220 | +2678.7 % | 4.003.502 |
| SSI INVESTMENT MANAGEMENT LLC | 7.398.000 | 1.243.000 | +20.2 % | 9.492.797 |
| MIZUHO MARKETS AMERICAS LLC | 1.268.673 | 926.526 | +270.8 % | 85.381.693 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 21.436.948 | -127.418.636 | -85.6 % | 128.346.295 |
| LINDEN ADVISORS LP | 12.993.000 | -67.930.000 | -83.9 % | 17.261.965 |
| Calamos Advisors LLC | 17.548.000 | -51.687.000 | -74.7 % | 26.850.557 |
| MACKAY SHIELDS LLC | 5.239.000 | -45.264.000 | -89.6 % | 5.645.263 |
| BlackRock, Inc. | 18.903.857 | -41.831.342 | -68.9 % | 892.884.859 |
| LAZARD ASSET MANAGEMENT LLC | 18.422.243 | -37.058.755 | -66.8 % | 3.487.589 |
| STATE STREET CORP | 14.759.672 | -21.324.535 | -59.1 % | 357.469.177 |
| BALYASNY ASSET MANAGEMENT L.P. | 14.785.000 | -20.293.000 | -57.9 % | 19.653.922 |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 39.626.000 | -15.620.000 | -28.3 % | 52.784.405 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 3.535.149 | -13.505.310 | -79.3 % | 17.871.861 |
Zusätzlich aktuell von 56 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 30.04.2026 | Vanguard Capital Management | Passiv (13G) | 5,21 % | 6.173.547 | Neu | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -10,04 pp | |
| 17.07.2025 | BlackRock, Inc. | Passiv (13G/A) | 10,20 % | 12.612.300 | -2,90 pp | |
| 13.05.2025 | STATE STREET CORPORATION | Passiv (13G) | 4,90 % | 6.053.007 | -0,30 pp | |
| 28.04.2025 | BlackRock, Inc. | Passiv (13G/A) | 13,10 % | 16.144.164 | Neu | |
| 12.11.2024 | Artisan Partners Asset Management Inc. | Passiv (13G/A) | 2,50 % | 3.133.412 | -2,60 pp | |
| 12.11.2024 | Artisan Partners Limited Partnership | Passiv (13G/A) | 2,50 % | 3.133.412 | -2,60 pp | |
| 12.11.2024 | Artisan Investments GP LLC | Passiv (13G/A) | 2,50 % | 3.133.412 | -2,60 pp | |
| 12.11.2024 | Artisan Partners Holdings LP | Passiv (13G/A) | 2,50 % | 3.133.412 | -2,60 pp | |
| 17.10.2024 | STATE STREET CORPORATION | Passiv (13G) | 5,20 % | 6.635.827 | Neu | |
| 13.02.2024 | The Vanguard Group | Passiv (13G/A) | 10,04 % | 13.259.514 | -0,23 pp | |
| 12.02.2024 | Artisan Investments GP LLC | Passiv (13G/A) | 5,10 % | 6.689.058 | Neu | |
| 12.02.2024 | Artisan Partners Asset Management Inc. | Passiv (13G/A) | 5,10 % | 6.689.058 | Neu | |
| 12.02.2024 | Artisan Partners Holdings LP | Passiv (13G/A) | 5,10 % | 6.689.058 | Neu | |
| 12.02.2024 | Artisan Partners Limited Partnership | Passiv (13G/A) | 5,10 % | 6.689.058 | Neu | |
| 01.02.2024 | Invesco Ltd. | Passiv (13G/A) | 2,10 % | 2.816.427 | -3,10 pp | |
| 23.01.2024 | . BlackRock, Inc. | Passiv (13G/A) | 14,10 % | 18.629.818 | -0,10 pp | |
| 09.06.2023 | The Vanguard Group | Passiv (13G/A) | 10,27 % | 13.528.630 | +0,43 pp | |
| 10.02.2023 | . BlackRock, Inc. | Passiv (13G/A) | 14,20 % | 19.196.061 | +0,60 pp | |
| 10.02.2023 | Artisan Partners Limited Partnership | Passiv (13G/A) | 5,30 % | 7.140.953 | -1,50 pp | |
| 10.02.2023 | Artisan Partners Holdings LP | Passiv (13G/A) | 5,30 % | 7.140.953 | -1,50 pp | |
| 10.02.2023 | Artisan Partners Asset Management Inc. | Passiv (13G/A) | 5,30 % | 7.140.953 | -1,50 pp | |
| 10.02.2023 | Artisan Investments GP LLC | Passiv (13G/A) | 5,30 % | 7.140.953 | -1,50 pp | |
| 10.02.2023 | Invesco Ltd. | Passiv (13G) | 5,20 % | 7.036.951 | Neu | |
| 09.02.2023 | The Vanguard Group | Passiv (13G/A) | 9,84 % | 13.303.847 | -0,18 pp | |
| 26.01.2023 | . BlackRock, Inc. | Passiv (13G/A) | 13,60 % | 18.214.071 | 0,00 pp | |
| 20.01.2023 | . BlackRock, Inc. | Passiv (13G) | 13,60 % | 18.214.071 | -0,20 pp | |
| 12.12.2022 | The Vanguard Group | Passiv (13G/A) | 10,02 % | 13.542.589 | +0,43 pp | |
| 10.02.2022 | The Vanguard Group | Passiv (13G/A) | 9,59 % | 13.495.913 | -0,14 pp | |
| 04.02.2022 | Artisan Investments GP LLC | Passiv (13G/A) | 6,80 % | 9.505.768 | -0,80 pp | |
| 04.02.2022 | Artisan Partners Holdings LP | Passiv (13G/A) | 6,80 % | 9.505.768 | -0,80 pp | |
| 04.02.2022 | Artisan Partners Limited Partnership | Passiv (13G/A) | 6,80 % | 9.505.768 | -0,80 pp | |
| 04.02.2022 | Artisan Partners Asset Management Inc. | Passiv (13G/A) | 6,80 % | 9.505.768 | -0,80 pp | |
| 28.01.2022 | . BlackRock, Inc. | Passiv (13G/A) | 13,80 % | 19.439.863 | +0,10 pp |
US Congress Trades (STOCK Act)
| Datum | Mitglied | Partei | Kammer | Typ | Betrag-Bereich |
|---|---|---|---|---|---|
| 09.03.2026 | Gilbert Cisneros | – | House | Kauf | $1,001 – $15,000 |
Quelle: House eFD & Senate eFD (STOCK Act PTR). Betragsangaben sind Bereichsangaben — keine Exaktwerte. Tiefenanalyse für diese Aktie → · Alle Kongress-Bestände →
Stammdaten
Halozyme Therapeutics, Inc. ist ein Biopharma-Technologieplattformunternehmen in den Vereinigten Staaten, der Schweiz, Irland, Belgien, Japan und international. Die Produkte des Unternehmens basieren auf der ENHANZE-Arzneimittelabgabetechnologie, einem patentierten rekombinanten menschlichen Hyaluronidase-Enzym (rHuPH20), das die subkutane Verabreichung biologischer Injektionsmittel wie monoklonaler Antikörper und anderer therapeutischer Moleküle sowie kleinmolekularer Substanzen und Flüssigkeiten ermöglicht. Das Flaggschiff-Produkt ist Hylenex recombinant, eine Formulierung von rHuPH20 zur Erleichterung der subkutanen Flüssigkeitsverabreichung für die Hydratation, um die Ausbreitung und Absorption anderer injizierter Arzneimittel in der subkutanen Urographie zu verbessern und die Resorption von radioopaken Mitteln zu verbessern. Das Unternehmen entwickelt auch Perjeta; RITUXAN HYCELA und MabThera SC zur Behandlung von Non-Hodgkin-Lymphom und chronisch lymphatischer Leukämie (CLL); RITUXAN SC für Patienten mit CLL; und HYQVIA zur Behandlung von Immunmangelstörungen. Darüber hinaus entwickelt es Tecentriq für Nicht-kleinzelliges Lungenkarzinom; OCREVUS für Multiple Sklerose; DARZALEX zur Behandlung von Patienten mit Amyloidose, schwelender Myelom und Multiplem Myelom; Nivolumab zur Behandlung solider Tumoren; ARGX-113, einen menschlichen neonatalen Fc-Rezeptor; ARGX-117 zur Behandlung von Autoimmunerkrankungen; und BMS-986179, einen Anti-CD-73-Antikörper. Das Unternehmen kooperiert mit F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; und ViiV Healthcare Limited an klein- und großmolekularen Zielen zur Behandlung und Prävention von HIV. Halozyme Therapeutics, Inc. wurde 1998 gegründet und hat seinen Sitz in San Diego, Kalifornien.
Unternehmen & Branche
| Name | HALOZYME THERAPEUTICS, INC. |
|---|---|
| Ticker | HALO |
| CIK | 0001159036 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 40637H109 |
|---|---|
| ISIN | US40637H1095 |
| Typ | Common Stock |
| Marktkapitalisierung | 8,19 Mrd. USD |
| KGV (P/E) | 27,15 |
| Beta | 0,87 |
Bewertung
| KBV (P/B) | 167,69 vs. 28,07 (2021) ▲ |
|---|---|
| KUV (P/S) | 5,86 vs. 12,47 (2021) ▼ |
| EV/EBITDA | 21,2 vs. 22,5 (2021) ▼ |
| FCF-Rendite | 7,9 % vs. 5,4 % (2021) ▲ |
| Buyback-Rendite | 4,2 % vs. 6,3 % (2021) ▼ |
Qualität & Bilanz
| Bruttomarge | 83,6 % vs. 81,6 % (2021) ▲ |
|---|---|
| Operative Marge | 33,6 % vs. 62,2 % (2021) ▼ |
| Nettomarge | 22,7 % vs. 90,8 % (2021) ▼ |
| ROIC | 14,5 % vs. 37,5 % (2021) ▼ |
| Nettoverschuldung/EBITDA | 4,2 vs. 2,7 (2021) ▲ |
| Zinsdeckungsgrad | 25,9 vs. 36,7 (2021) ▼ |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 28,07 | 45,29 | 55,91 | 16,18 | 162,39 | |
| KUV (P/S) | 12,47 | 11,65 | 5,65 | 5,80 | 5,68 | |
| EV/EBITDA | 22,5 | 32,7 | 17,4 | 13,0 | 20,7 | |
| FCF-Rendite | 5,4 % | 3,1 % | 8,0 % | 8,0 % | 8,1 % | |
| Buyback-Rendite | 6,3 % | 2,6 % | 8,6 % | 4,2 % | 4,3 % | |
| Qualität & Bilanz | ||||||
| Bruttomarge | 81,6 % | 78,9 % | 76,8 % | 84,3 % | 83,6 % | |
| Operative Marge | 62,2 % | 40,5 % | 40,7 % | 54,3 % | 33,6 % | |
| Nettomarge | 90,8 % | 30,6 % | 34,0 % | 43,7 % | 22,7 % | |
| ROIC | 37,5 % | 12,1 % | 17,8 % | 23,8 % | 14,5 % | |
| Nettoverschuldung/EBITDA | 2,7 | 4,6 | 4,0 | 2,5 | 4,2 | |
| Zinsdeckungsgrad | 36,7 | 15,8 | 18,0 | 30,5 | 25,9 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 376.708.000 | 150.049.000 | 1,22 | 2.672.719.000 | 219.636.000 |
| 2025-12-31 | 10-K | 1.396.611.000 | 316.889.000 | 2,56 | 2.525.323.000 | 48.814.000 |
| 2025-09-30 | 10-Q | 354.264.000 | 175.225.000 | 1,43 | 2.221.232.000 | 503.915.000 |
| 2025-06-30 | 10-Q | 325.719.000 | 165.160.000 | 1,33 | 2.053.899.000 | 332.748.000 |
| 2025-03-31 | 10-Q | 264.861.000 | 118.095.000 | 0,93 | 2.196.532.000 | 482.270.000 |
| 2024-12-31 | 10-K | 1.015.324.000 | 444.091.000 | 3,43 | 2.063.477.000 | 363.821.000 |
| 2024-09-30 | 10-Q | 290.084.000 | 137.011.000 | 1,05 | 2.118.030.000 | 452.703.000 |
| 2024-06-30 | 10-Q | 231.353.000 | 93.245.000 | 0,72 | 1.969.453.000 | 289.424.000 |
| 2024-03-31 | 10-Q | 195.879.000 | 76.823.000 | 0,60 | 1.841.527.000 | 177.808.000 |
| 2023-12-31 | 10-K | 829.253.000 | 281.594.000 | 2,10 | 1.733.270.000 | 83.808.000 |
| 2023-09-30 | 10-Q | 216.033.000 | 81.837.000 | 0,61 | 1.892.662.000 | 249.181.000 |
| 2023-06-30 | 10-Q | 221.038.000 | 74.754.000 | 0,56 | 1.810.440.000 | 151.033.000 |
| 2023-03-31 | 10-Q | 162.143.000 | 39.615.000 | 0,29 | 1.699.447.000 | 65.850.000 |
| 2022-12-31 | 10-K | 660.116.000 | 202.129.000 | 1,44 | 1.841.511.000 | 169.798.000 |
| 2022-09-30 | 10-Q | 208.976.000 | 61.634.000 | 0,44 | 1.864.543.000 | 96.991.000 |
| 2022-06-30 | 10-Q | 152.365.000 | 22.685.000 | 0,16 | 1.781.390.000 | 293.171.000 |
| 2022-03-31 | 10-Q | 117.279.000 | 60.108.000 | 0,43 | 1.162.248.000 | 260.256.000 |
| 2021-12-31 | 10-K | 443.310.000 | 402.710.000 | 2,74 | 1.104.429.000 | 196.953.000 |
| 2021-09-30 | 10-Q | 115.830.000 | 216.587.000 | 1,48 | 1.185.420.000 | 281.674.000 |
| 2021-06-30 | 10-Q | 136.455.000 | 91.458.000 | 0,62 | 1.025.863.000 | 119.746.000 |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| Royalty | 867,8 Mio. | 571,0 Mio. | 447,9 Mio. | 360,5 Mio. | 203,9 Mio. | 45,1 % | +52,0% | |
| Product | 376,4 Mio. | 303,5 Mio. | 300,9 Mio. | 191,0 Mio. | 104,2 Mio. | 19,6 % | +24,0% | |
| Proprietary Products Sales | 194,6 Mio. | 166,6 Mio. | 130,8 Mio. | 72,8 Mio. | – | 10,1 % | +16,8% | |
| Collaborative Agreements | 152,3 Mio. | 140,8 Mio. | 80,5 Mio. | 108,6 Mio. | 135,2 Mio. | 7,9 % | +8,2% | |
| Bulk RHu PH 20 | 133,0 Mio. | 86,3 Mio. | 115,4 Mio. | 82,1 Mio. | – | 6,9 % | +54,1% | |
| Salesbasedmilestone | 70,0 Mio. | 30,0 Mio. | – | 10,0 Mio. | 50,0 Mio. | 3,6 % | +133,3% | |
| Device Partnered Products | 48,8 Mio. | 50,5 Mio. | 54,6 Mio. | 36,1 Mio. | – | 2,5 % | -3,4% | |
| Event Based Development And Regulatory Milestone And Other Fees | 47,0 Mio. | 72,5 Mio. | 69,0 Mio. | 59,0 Mio. | – | 2,4 % | -35,2% | |
| Upfront Fees | 18,5 Mio. | 27,0 Mio. | 2,0 Mio. | 30,0 Mio. | – | 1,0 % | -31,6% | |
| Device Licensing And Development | 16,9 Mio. | 11,3 Mio. | 9,5 Mio. | 9,6 Mio. | – | 0,9 % | +48,6% | |
| Bulkr Hu PH 20 | – | – | – | – | 81,0 Mio. | – | – | |
| Development Fees | – | – | – | – | 42,0 Mio. | – | – | |
| Upfrontfees | – | – | – | – | 42,0 Mio. | – | – | |
| Hylenex Recombinant | – | – | – | – | 23,3 Mio. | – | – | |
| Researchand Development Services | – | – | – | – | 1,2 Mio. | – | – |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 11.05.2026 | 376,7 Mio. USD | 1,22 |
| Q3 2025 | 30.09.2025 | 03.11.2025 | 354,3 Mio. USD | 1,43 |
| Q2 2025 | 30.06.2025 | 05.08.2025 | 325,7 Mio. USD | 1,33 |
| Q1 2025 | 31.03.2025 | 11.05.2026 | 264,9 Mio. USD | 0,93 |
| Q3 2024 | 30.09.2024 | 03.11.2025 | 290,1 Mio. USD | 1,05 |
| Q2 2024 | 30.06.2024 | 05.08.2025 | 231,4 Mio. USD | 0,72 |
| Q1 2024 | 31.03.2024 | 06.05.2025 | 195,9 Mio. USD | 0,60 |
| Q3 2023 | 30.09.2023 | 31.10.2024 | 216,0 Mio. USD | 0,61 |
| Q2 2023 | 30.06.2023 | 06.08.2024 | 221,0 Mio. USD | 0,56 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 11.05.2026 | 10-Q | 31.03.2026 | 41 Tage | SEC » |
| 17.02.2026 | 10-K | 31.12.2025 | 48 Tage | SEC » |
| 03.11.2025 | 10-Q | 30.09.2025 | 34 Tage | SEC » |
| 05.08.2025 | 10-Q | 30.06.2025 | 36 Tage | SEC » |
| 06.05.2025 | 10-Q | 31.03.2025 | 36 Tage | SEC » |
| 18.02.2025 | 10-K | 31.12.2024 | 49 Tage | SEC » |
| 31.10.2024 | 10-Q | 30.09.2024 | 31 Tage | SEC » |
| 06.08.2024 | 10-Q | 30.06.2024 | 37 Tage | SEC » |
| 07.05.2024 | 10-Q | 31.03.2024 | 37 Tage | SEC » |
| 20.02.2024 | 10-K | 31.12.2023 | 51 Tage | SEC » |
| 06.11.2023 | 10-Q | 30.09.2023 | 37 Tage | SEC » |
| 08.08.2023 | 10-Q | 30.06.2023 | 39 Tage | SEC » |
| 09.05.2023 | 10-Q | 31.03.2023 | 39 Tage | SEC » |
| 21.02.2023 | 10-K | 31.12.2022 | 52 Tage | SEC » |
| 08.11.2022 | 10-Q | 30.09.2022 | 39 Tage | SEC » |
| 09.08.2022 | 10-Q | 30.06.2022 | 40 Tage | SEC » |
| 10.05.2022 | 10-Q | 31.03.2022 | 40 Tage | SEC » |
| 22.02.2022 | 10-K | 31.12.2021 | 53 Tage | SEC » |
| 02.11.2021 | 10-Q | 30.09.2021 | 33 Tage | SEC » |
| 09.08.2021 | 10-Q | 30.06.2021 | 40 Tage | SEC » |
| 10.05.2021 | 10-Q | 31.03.2021 | 40 Tage | SEC » |
| 23.02.2021 | 10-K | 31.12.2020 | 54 Tage | SEC » |
| 02.11.2020 | 10-Q | 30.09.2020 | 33 Tage | SEC » |
| 10.08.2020 | 10-Q | 30.06.2020 | 41 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 09.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 08.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 24.11.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 06.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 21.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 13.02.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 23.02.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 06.02.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 15.03.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 03.02.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 13.12.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 05.05.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 03.05.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 24.02.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-26 | 1.046 | 68,32 | 71.463 |
| 2026-05-20 | 6 | 68,73 | 412 |
| 2026-05-19 | 16 | 67,44 | 1.079 |
| 2026-05-18 | 437 | 67,12 | 29.331 |
| 2026-05-13 | 662 | 70,93 | 46.956 |
| 2026-05-08 | 13 | 65,19 | 847 |
| 2026-05-04 | 1.646 | 63,96 | 105.278 |
| 2026-04-29 | 8.514 | 63,86 | 543.704 |
| 2026-04-28 | 950 | 64,49 | 61.265 |
| 2026-04-24 | 67 | 66,59 | 4.462 |
| 2026-04-23 | 215 | 68,40 | 14.706 |
| 2026-04-17 | 45 | 66,64 | 2.999 |
| 2026-04-16 | 36 | 68,05 | 2.450 |
| 2026-04-08 | 2.291 | 63,60 | 145.708 |
| 2026-04-02 | 1.226 | 65,40 | 80.180 |
| 2026-03-31 | 2 | 62,13 | 124 |
| 2026-03-27 | 2.106 | 63,29 | 133.289 |
| 2026-03-25 | 16 | 62,04 | 993 |
| 2026-03-24 | 628 | 62,86 | 39.476 |
| 2026-03-20 | 22 | 63,27 | 1.392 |
| 2026-03-18 | 52 | 65,13 | 3.387 |
| 2026-03-13 | 27.130 | 63,56 | 1.724.383 |
| 2026-03-12 | 59 | 66,48 | 3.922 |
| 2026-03-09 | 13.166 | 67,37 | 886.993 |
| 2026-02-26 | 147 | 70,35 | 10.341 |
| 2026-02-19 | 489 | 73,23 | 35.809 |
| 2026-02-11 | 5.611 | 80,22 | 450.114 |
| 2026-02-09 | 97 | 81,23 | 7.879 |
| 2026-02-05 | 2 | 77,93 | 156 |
| 2026-02-04 | 27.392 | 76,48 | 2.094.940 |
| 2026-02-03 | 3.111 | 74,45 | 231.614 |
| 2026-01-28 | 7.772 | 70,22 | 545.750 |
| 2026-01-27 | 10.380 | 69,87 | 725.251 |
| 2026-01-26 | 10.294 | 69,22 | 712.551 |
| 2026-01-14 | 8.670 | 71,67 | 621.379 |
| 2026-01-13 | 296 | 72,42 | 21.436 |
| 2026-01-08 | 92 | 75,11 | 6.910 |
| 2026-01-05 | 33 | 70,31 | 2.320 |
| 2025-12-31 | 57.660 | 67,70 | 3.903.582 |
| 2025-12-30 | 552 | 68,95 | 38.060 |
| 2025-12-23 | 2 | 68,16 | 136 |
| 2025-12-22 | 785 | 67,35 | 52.870 |
| 2025-12-18 | 30.994 | 65,77 | 2.038.475 |
| 2025-12-17 | 12 | 64,47 | 774 |
Hinweis
Ersteller: Verantwortlich für Erstellung und Verbreitung ist der Betreiber dieser Website (siehe Impressum). Die Einstufung wird arbeitstäglich automatisiert neu berechnet — Stand: 16.06.2026.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in besprochenen Werten halten. Methodik: Signal-Komponenten und Gewichte.